These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3789968)

  • 1. Inaccuracy in preparation of intravitreal solutions.
    Noske W
    Arch Ophthalmol; 1986 Dec; 104(12):1748-9. PubMed ID: 3789968
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of intravitreal drug doses.
    Jeglum EL; Rosenberg SB; Benson WE
    Ophthalmic Surg; 1981 May; 12(5):355-9. PubMed ID: 7266982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal antibiotics: accuracy of dilution by pharmacists, ophthalmologists, and ophthalmic assistants, using three protocols.
    Narvaez J; Wessels IF; Mattheis JK; Beierle F
    Ophthalmic Surg; 1992 Apr; 23(4):265-8. PubMed ID: 1589197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
    Rao R; Honavar SG; Sharma V; Reddy VAP
    Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravitreal administration of drugs].
    Cârstocea B; Macovei L
    Oftalmologia; 2005; 49(2):5-9. PubMed ID: 16245736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
    Francis JH; Abramson DH; Gaillard MC; Marr BP; Beck-Popovic M; Munier FL
    Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
    Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
    Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs.
    Carnota-Méndez P; Méndez-Vázquez C; Otero-Villar J; Saavedra-Pazos JA
    Eur J Ophthalmol; 2014; 24(5):771-7. PubMed ID: 24706353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ULTRASONOGRAPHIC FINDINGS IN THE VITREOUS OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.
    Mato-Gondelle T; Bande MF; Paniagua L; Rodríguez-Cid MJ; Abraldes M; Fernández M; Blanco-Teijeiro MJ; Piñeiro A
    Retina; 2018 Oct; 38(10):1962-1967. PubMed ID: 28820850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimizing the risk of endophthalmitis following intravitreal injections.
    Lad EM; Moshfeghi DM
    Compr Ophthalmol Update; 2006; 7(6):277-84; discussion 285-6. PubMed ID: 17244443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal detachment from hyperosmotic intravitreal injection.
    Marmor MF
    Invest Ophthalmol Vis Sci; 1979 Dec; 18(12):1237-44. PubMed ID: 116971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release kinetics of liposome-encapsulated ganciclovir after intravitreal injection in rabbits.
    Le Bourlais C; Chevanne F; Ropert P; Bretagne G; Acar L; Zia H; Sado PA; Needham T; Leverge R
    J Microencapsul; 1996; 13(4):473-80. PubMed ID: 8808783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Presumed Silicone Oil Droplets in the Vitreous Cavity After Intravitreal Bevacizumab Injection With Insulin Syringes.
    Khurana RN; Chang LK; Porco TC
    JAMA Ophthalmol; 2017 Jul; 135(7):800-803. PubMed ID: 28617905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H; Koç İ; Varan A; Akyüz C
    Eur J Ophthalmol; 2017 Jun; 27(4):423-427. PubMed ID: 28106239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide.
    Degenring RF; Sauder G
    Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):1043-4. PubMed ID: 16365736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of intravitreal voriconazole.
    Shen YC; Wang MY; Wang CY; Tsai TC; Tsai HY; Lee YF; Wei LC
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2238-41. PubMed ID: 17460285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.